IL215264A0 - Lipopeptide inhibitors of hiv-1 - Google Patents

Lipopeptide inhibitors of hiv-1

Info

Publication number
IL215264A0
IL215264A0 IL215264A IL21526411A IL215264A0 IL 215264 A0 IL215264 A0 IL 215264A0 IL 215264 A IL215264 A IL 215264A IL 21526411 A IL21526411 A IL 21526411A IL 215264 A0 IL215264 A0 IL 215264A0
Authority
IL
Israel
Prior art keywords
lipopeptide
hiv
inhibitors
lipopeptide inhibitors
Prior art date
Application number
IL215264A
Original Assignee
Yeda Res & Dev
Yechiel Shai
Yael Wexler Cohen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2010/000271 external-priority patent/WO2010113157A1/en
Application filed by Yeda Res & Dev, Yechiel Shai, Yael Wexler Cohen filed Critical Yeda Res & Dev
Priority to IL215264A priority Critical patent/IL215264A0/en
Publication of IL215264A0 publication Critical patent/IL215264A0/en

Links

IL215264A 2009-04-01 2011-09-20 Lipopeptide inhibitors of hiv-1 IL215264A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL215264A IL215264A0 (en) 2009-04-01 2011-09-20 Lipopeptide inhibitors of hiv-1

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16553609P 2009-04-01 2009-04-01
PCT/IL2010/000271 WO2010113157A1 (en) 2009-04-01 2010-03-28 Lipopeptide inhibitors of hiv-1
IL215264A IL215264A0 (en) 2009-04-01 2011-09-20 Lipopeptide inhibitors of hiv-1

Publications (1)

Publication Number Publication Date
IL215264A0 true IL215264A0 (en) 2011-12-29

Family

ID=45768379

Family Applications (1)

Application Number Title Priority Date Filing Date
IL215264A IL215264A0 (en) 2009-04-01 2011-09-20 Lipopeptide inhibitors of hiv-1

Country Status (1)

Country Link
IL (1) IL215264A0 (en)

Similar Documents

Publication Publication Date Title
AP2925A (en) Inhibitors of human immunodeficiency virus replication
ZA201303433B (en) Inhibitors of hiv replication
EP2542074A4 (en) Combination pharmaceutical agents as inhibitors of hcv replication
IL218018A0 (en) Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions
IL212786A (en) 4-amino- 4-oxobutanoyl peptides as inhibitors of viral replication
EP2438246A4 (en) Aspects of construction
ZA201206456B (en) Uses of dgati inhibitors
IL214606A0 (en) Inhibitors of hiv replication
HUE053793T2 (en) Uses of hypoxia-inducible factor inhibitors
HK1171624A1 (en) Inhibitors of cognitive decline
HK1167323A1 (en) Inhibitors of cognitive decline
HK1167654A1 (en) Dihydropyrrolonaphtyridinone compounds as inhibitors of jak jak dihydropyrrolonaphtyridinone
EP2635287A4 (en) Administration of nedd8-activating enzyme inhibitor
EP2496230A4 (en) Ire-1 alpha inhibitors
EP2478010A4 (en) Partial peptide of lacritin
EP2470014A4 (en) Hiv integrase inhibitors
IL217756A0 (en) Inhibitors of jnk
EP2432885A4 (en) Methods for enhancing infectivity of retroviruses
SI2411376T1 (en) Inhibitors of nf-kb
EP2501803A4 (en) Methods of enhancing pluripotentcy
IL215264A0 (en) Lipopeptide inhibitors of hiv-1
IL215486A0 (en) Compositions of cholinesterase inhibitors
ZA201200531B (en) Pharmaceutical composition of rifampicin
GB0903651D0 (en) Inhibitors of glyoxalase
GB0908609D0 (en) New use of isoQC inhibitors